APOG
Apogee Enterprises, Inc.
APOG has the edge over RKLB overall, supported by lower modeled downside and stronger fundamentals.
RKLB
Rocket Lab USA, Inc.
RKLB offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
APOG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Stable |
APOG's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
APOG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $33.73 | -29% |
| Forward | 14x | $47.41 | — |
| Fair | 15x | $46.28 | -2.4% |
| Current | 15x | $47.41 | — |
| Expensive | 44x | $139 | +193% |
Historical ranges are pointers, not guarantees.
APOG's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
APOG Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for APOG, with profitability holding steady.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RKLB has the edge over APOG on the outlook, with more favorable profitability expectations.
APOG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.37 | +6.6% |
| Q3 2026 | $3.16 | +54% |
| Q2 2026 | $3.19 | +36% |
| Q1 2026 | $2.52 | -35% |
| Q4 2025 | $1.86 | -58% |
| Q3 2025 | $2.05 | -57% |
| Q2 2025 | $2.35 | -52% |
| Q1 2025 | $3.89 | -14% |
| Q4 2024 | $4.48 | -4.5% |
APOG has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
APOG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $391.1M | +9.2% |
| Q2 2026 | $342.7M | -1.1% |
| Q1 2026 | $351.4M | +1.6% |
| Q4 2025 | $348.6M | +2.1% |
| Q3 2025 | $358.2M | +4.6% |
| Q2 2025 | $346.6M | +4.6% |
| Q1 2025 | $345.7M | -4.5% |
| Q4 2024 | $341.3M | +0.5% |
APOG's revenue grew through 2022 and has held roughly level since: $391M last quarter, up 9.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.6% | +1.1 points |
| Q2 2026 | 5.5% | +3.5 points |
| Q1 2026 | 7.3% | +5.6 points |
| Q4 2025 | 7.1% | -1.3 points |
| Q3 2025 | 7.5% | -4.7 points |
| Q2 2025 | 2% | -11 points |
| Q1 2025 | 1.8% | -4.3 points |
| Q4 2024 | 8.4% | -2.7 points |
APOG has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over APOG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
APOG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $24.3M | -54% |
| Q2 2026 | $1.1M | +$28.1M |
| Q1 2026 | $46.9M | +145% |
| Q4 2025 | $22.9M | +4.1% |
| Q3 2025 | $52.4M | +4.3% |
| Q2 2025 | -$26.9M | -$25.2M |
| Q1 2025 | $19.1M | -67% |
| Q4 2024 | $22M | -60% |
APOG has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
APOG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.9% | -411K shares |
| 1 year | -3.2% | -689K shares |
| 3 years | -4.8% | -1.1M shares |
| 5 years | -17% | -4.2M shares |
| Available history | -22% | -5.8M shares |
APOG has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6.4M |
| Q2 2026 | $9.7M |
| Q1 2026 | $15M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $30.3M |
| Q4 2024 | — |
APOG spent $31M buying back its own shares over the past year, up 2.6% from the year before.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
APOG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 1.4x | Healthy |
| Q1 2026 | 1.4x | Healthy |
| Q4 2025 | 1.8x | Healthy |
| Q3 2025 | 2.0x | Healthy |
| Q2 2025 | 2.1x | Moderate |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | 1.3x | Healthy |
APOG's net debt is about 1.9 years of its operating earnings (EBITDA), about the same as a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
APOG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.6 | Neutral |
| Stochastic | 85.8 | Overbought |
APOG's weekly RSI is 64 (neutral) and its Stochastic is 86 (overbought).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
APOG PE vs Industrials Sector
| Metric | APOG | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 24x | 38% below |
| PE % | 52 | 58 | 6 pts below |
APOG is trading at 15x earnings, a 38% discount to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
APOG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $42.1 | 13% above |
| 20 week MA | $41.0 | 16% above |
| 50 week MA | $39.0 | 22% above |
| 100 week MA | $42.0 | 13% above |
| 200 week MA | $48.7 | 2.6% below |
APOG has the edge over RKLB on trend strength, trading above more of its moving averages.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
APOG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.5 | $32.7 | +0.5% |
| 2021 | $32.7 | $47.2 | +44% |
| 2022 | $47.2 | $43.9 | -7% |
| 2023 | $43.9 | $53.4 | +22% |
| 2024 | $53.4 | $72.3 | +35% |
| 2025 | $72.3 | $38.0 | -48% |
| 2026 YTD | $38.0 | $47.4 | +25% |
APOG has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.